WHAT: Cenduit, a joint venture between Quintiles and Thermo Fisher Scientific, is showcasing its solutions and expertise as the largest interactive response technology (IRT) specialist in the world at IRT Europe June 13-14 in London, United Kingdom.
Cenduit Senior Director of Project Management Stefan Dürr will discuss the capabilities for “Intelligent Clinical Supply Forecasting and Simulations through IRT” during the conference. His presentation will cover opportunities for enhanced clinical supply chain management using IRT, including tips for optimizing clinical supply forecasting and reducing overages with simulation tools that offer real-time patient engagement data. Dürr will also highlight advanced IRT analytics that drive all aspects of optimized decision support and insights.
Stop by Cenduit’s booth to learn about how the company’s IRT solutions can help sponsors reduce costs and ensure optimizations through clinical supply forecasting, simulations and predictive analytics.
WHO: Cenduit attendees include:
• Stefan Dürr, senior director, project management, Cenduit
• Bruno Feder, director, account management, Cenduit
• Dan Pavitt, associate director, account management, Cenduit
WHEN: June 13, 2016, 8:00 a.m. to June 14, 2016, 3 p.m.
WHERE: Amba Hotel Marble Arch
W1H 7EH
London, United Kingdom
DETAILS: For media inquiries, please contact Kelly Maicon at Largemouth Communications, (919) 459-6456 kmaicon@largemouthpr.com.
ABOUT: Cenduit, a joint venture between Quintiles and Thermo Fisher Scientific, is the largest IRT specialist in the world with the expertise to empower sponsors for success by implementing a completely personalized system that puts them in control of their clinical trials. With the needs of investigator sites and patients top of mind, Cenduit offers clinical supply chain intelligence and clinical operations know-how through its IRT-driven services: patient randomization, patient reminders, drug supply management, and eClinical integration. Cenduit has offices in the US, UK, Switzerland, India, and Japan, and global clinical trial experience in more than 100 countries, interacting with more than 600,000 patients at more than 32,000 sites. For additional information, visit Cenduit online at www.cenduit.com; on Twitter @CenduitLLC or on LinkedIn at www.LinkedIn.com/Company/Cenduit.
Cenduit Senior Director of Project Management Stefan Dürr will discuss the capabilities for “Intelligent Clinical Supply Forecasting and Simulations through IRT” during the conference. His presentation will cover opportunities for enhanced clinical supply chain management using IRT, including tips for optimizing clinical supply forecasting and reducing overages with simulation tools that offer real-time patient engagement data. Dürr will also highlight advanced IRT analytics that drive all aspects of optimized decision support and insights.
Stop by Cenduit’s booth to learn about how the company’s IRT solutions can help sponsors reduce costs and ensure optimizations through clinical supply forecasting, simulations and predictive analytics.
WHO: Cenduit attendees include:
• Stefan Dürr, senior director, project management, Cenduit
• Bruno Feder, director, account management, Cenduit
• Dan Pavitt, associate director, account management, Cenduit
WHEN: June 13, 2016, 8:00 a.m. to June 14, 2016, 3 p.m.
WHERE: Amba Hotel Marble Arch
W1H 7EH
London, United Kingdom
DETAILS: For media inquiries, please contact Kelly Maicon at Largemouth Communications, (919) 459-6456 kmaicon@largemouthpr.com.
ABOUT: Cenduit, a joint venture between Quintiles and Thermo Fisher Scientific, is the largest IRT specialist in the world with the expertise to empower sponsors for success by implementing a completely personalized system that puts them in control of their clinical trials. With the needs of investigator sites and patients top of mind, Cenduit offers clinical supply chain intelligence and clinical operations know-how through its IRT-driven services: patient randomization, patient reminders, drug supply management, and eClinical integration. Cenduit has offices in the US, UK, Switzerland, India, and Japan, and global clinical trial experience in more than 100 countries, interacting with more than 600,000 patients at more than 32,000 sites. For additional information, visit Cenduit online at www.cenduit.com; on Twitter @CenduitLLC or on LinkedIn at www.LinkedIn.com/Company/Cenduit.